1. Age â?¥18 years at time of participation in the study <br/ >2. Laboratory (RT-PCR) confirmed infection with 2019-nCoV <br/ >3. Willingness of study participant to accept randomization to any assigned treatment arm <br/ >4. Must agree not to enrol in another study of an investigational agent prior to completion of the present study <br/ >

1. Age â?¥18 years at time of participation in the study <br/ >2. Laboratory (RT-PCR) confirmed infection with 2019-nCoV <br/ >3. Willingness of study participant to accept randomization to any assigned treatment arm <br/ >4. Must agree not to enrol in another study of an investigational agent prior to completion of the present study <br/ >

1. Age â?¥18 years at time of participation in the study <br/ >2. Laboratory (RT-PCR) confirmed infection with 2019-nCoV <br/ >3. Willingness of study participant to accept randomization to any assigned treatment arm <br/ >4. Must agree not to enrol in another study of an investigational agent prior to completion of the present study <br/ >

1. Age â?¥18 years at time of participation in the study <br/ >2. Laboratory (RT-PCR) confirmed infection with 2019-nCoV <br/ >3. Willingness of study participant to accept randomization to any assigned treatment arm <br/ >4. Must agree not to enrol in another study of an investigational agent prior to completion of the present study <br/ >